The Importance of Waiting for Biomarker Results in NSCLC

IASLC (International Association for the Study of Lung Cancer) shared a post on X:

“Biomarkers are essential in lung cancer treatment. Clinicians and patients have to wait for results before starting therapy. Stephen V Liu guides a discussion about biomarkers, and challenges/issues they create. With guests Ilit Turgeman, Dr. Mark Kris, and Aurora Lucas.”

Proceed to the discussion.
Source: IASLC/X